Good cholesterol, medically known as HDL (High-Density Lipoprotein), plays a vital role in maintaining heart health. Unlike bad cholesterol (LDL), which can accumulate in the arteries and increase the ...

High cholesterol has no visible symptoms, but it can have a profound impact on your heart health. While cholesterol-lowering medication is vital for some people, almost everyone could benefit from ...

A potential alternative to statins could help manage dangerously high cholesterol levels, according to scientists.

There has been an increase in heart attacks and heart-related events. While most reports suggest that such cardiac events are sudden, this is not entirely true. A majority of people only focus on ...

Your cholesterol levels—whether they are in range or dangerously high—are a key indicator of your risk of developing heart disease. And according to the Centers for Disease Control and Prevention (CDC ...

Cholesterol-related heart disease remains the leading cause of death worldwide. The post Scientists find alternative drug to ...

A new study explores the cholesterol-lowering effects of a new drug called enlicitide. Nicole Mason/Stocksy A recent study, published in JAMA on November 9, investigates a drug called enlicitide. The ...

A combination of four types of foods that could help reduce LDL cholesterol levels ...

A recent study published in Engineering has shed new light on the relationship between cholesterol levels and mortality risks. The research, conducted by a team of scientists from multiple ...

Researchers have developed a DNA-based therapy that targets the PCSK9 gene to lower cholesterol naturally. Using polypurine hairpins, they increased cholesterol uptake by cells and reduced ...

A new breakthrough could change how high cholesterol is treated, offering a powerful alternative to traditional drugs. Researchers have developed tiny DNA-based molecules that shut down PCSK9—a key ...

Enlicitide decanoate, an oral proprotein convertase subtilisin–kexin type 9 (PCSK9) inhibitor, was shown to reduce low-density lipoprotein (LDL) cholesterol levels in a phase 2 trial; longer-term data ...